Cite
APA Citation
Modlin, I. M., Kidd, M., Frilling, A., Falconi, M., Filosso, P. L., Malczewska, A., & Kitz, A. (2021). molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy. Annals of surgery, 274(3), . http://access.bl.uk/ark:/81055/vdc_100146089265.0x000042